The EU's medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.
After a study looking at 86 European cases, the European Medicines Agency (EMA) concluded the benefits of the vaccine outweighed the risk.
Libro degli ospiti: lasciateci i vostri commenti
Data 09.04.2021
Autore RonaldLok
Oggetto The benefits of the AstraZeneca vaccine
———
Indietro